𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of the M-2 protocol in previously untreated patients with advanced multiple myeloma

✍ Scribed by G�ssinger, H. ;Bettelheim, P. ;Neumann, E. ;Hinterberger, W. ;Korninger, K. ;Niessner, H. ;Pabinger-Fasching, I. ;Bauer, K. ;Lechner, K.

Book ID
104720736
Publisher
Springer-Verlag
Year
1984
Weight
347 KB
Volume
49
Category
Article
ISSN
1432-0584

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon alfa-2b/melphalan/prednisone
Interferon alfa-2b/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I–II trial
✍ M. Robert Cooper; Alexander Fefer; John Thompson; Delvyn C. Case; Raymond Kempf; 📂 Article 📅 1987 🏛 Springer US 🌐 English ⚖ 419 KB

Interferon alfa-2b (Intron A; Schering Plough) has been shown to be active in advanced previously treated multiple myeloma (MM). Recent in vitro evidence has suggested synergy between cytotoxic agents and interferon alfa-2b. This phase I-II protocol was initiated to study interferon alfa-2b in combi